A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Reneo Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 92,913 shares of RPHM stock, worth $156,093. This represents 0.0% of its overall portfolio holdings.

Number of Shares
92,913
Previous 10,906 751.94%
Holding current value
$156,093
Previous $16,000 881.25%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.34 - $1.7 $109,889 - $139,411
82,007 Added 751.94%
92,913 $157,000
Q2 2024

Aug 14, 2024

SELL
$1.51 - $1.9 $83,410 - $104,954
-55,239 Reduced 83.51%
10,906 $16,000
Q1 2024

May 15, 2024

BUY
$1.59 - $1.74 $89,798 - $98,269
56,477 Added 584.16%
66,145 $109,000
Q4 2023

Feb 14, 2024

SELL
$1.34 - $8.43 $6,583 - $41,416
-4,913 Reduced 33.69%
9,668 $15,000
Q3 2023

Nov 14, 2023

SELL
$5.44 - $8.13 $86,729 - $129,616
-15,943 Reduced 52.23%
14,581 $111,000
Q2 2023

Aug 14, 2023

BUY
$5.44 - $10.5 $166,050 - $320,502
30,524 New
30,524 $200,000
Q3 2022

Nov 14, 2022

SELL
$2.35 - $4.85 $62,126 - $128,219
-26,437 Reduced 15.32%
146,148 $490,000

Others Institutions Holding RPHM

About Reneo Pharmaceuticals, Inc.


  • Ticker RPHM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,479,600
  • Market Cap $41.1M
  • Description
  • Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...
More about RPHM
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.